Drug Trial Radar · NCT02739568
Pitolisant (BF2.649) in the Treatment of EDS in Patients With OSA
Last checked: Nov 19, 2026Latest source record: Jul 8, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
389
Actual
Start
Apr 2016
Primary completion
Apr 2020
Study completion Apr 2020
Sponsor
- Lead sponsor
- BioprojetAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 15, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The first objective of this study is to demonstrate the efficacy and safety of pitolisant given at 10, 20, or 40 mg per day versus placebo during 12 weeks of the Double Blind period, to treat the Excessive Daytime Sleepiness (EDS) in patients with Obstructive Sleep Apnea (OSA) refusing the nasal Continuous Positive Airway Pressure (nCPAP) therapy or treated by nCPAP but still complaining of EDS. The secondary objectives of the study include assessing the long-term tolerance as well as the maintenance of efficacy of pitolisant given at 10, 20 or 40 mg per day during 39 weeks of Open Label Extension period and further investigating the co-variates or co-medications that affect the pharmacokinetics of pitolisant in the target population.
Conditions
- Excessive Daytime Sleepiness
- Obstructive Sleep Apnea
Interventions
Pitolisant (BF2.649)Drug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Epworth sleepiness scale (ESS)Time frame: at weeks 12 and 52
Locations
6 sites in 2 countries. Site status is shown where the registry gives one.
Specialised Hospital for Active Treatment of pneumo-phthisiatric diseases - Burgas" EOOD, Pneumology ward
Burgas, Bulgaria
Multiprofile Hospital for Active Treatment "Sv. Ivan Rilski" EOOD
Kozloduy, Bulgaria
Multiprofile Hospital for Active Treatment "Sv. Paraskeva" OOD
Pleven, Bulgaria
University Multiprofile Hospital for Active Treatment "Kaspela" EOOD Clinic of thoracic surgery
Plovdiv, Bulgaria
University Multiprofile Hospital for Active Treatment "Aleksandrovska" EAD
Sofia, Bulgaria
Hospital of Skopje
Skopje, North Macedonia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.